ROBERT CG MARTIN

Allopathic & Osteopathic Physicians|Surgery|Surgical Oncology LOUISVILLE, KY NPI 1619947504

General Payments — all program years on this page

$547,319.93

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 274
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $19,208.44 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $18,700.004
Food and Beverage $508.4415

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
AngioDynamics, Inc. $18,921.147
ABBVIE INC. $98.214
Takeda Pharmaceuticals U.S.A., Inc. $72.481
Abbott Laboratories $37.932
Astellas Pharma US Inc $27.942
Acerta Pharma LLC $18.961
Ethicon US, LLC $16.751
EISAI INC. $15.031

By program year

Program yearAmountRecords
2018 $103,328.1536
2019 $116,184.0766
2020 $78,966.4629
2021 $74,605.2431
2022 $66,598.8946
2023 $88,428.6847
2024 $19,208.4419

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077632092 Ethicon US, LLC $16.75 07/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1095086176 AngioDynamics, Inc. $2,750.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1095086180 AngioDynamics, Inc. $125.74 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1095086183 AngioDynamics, Inc. $6,600.00 05/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1095086186 AngioDynamics, Inc. $6,600.00 10/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1095086190 AngioDynamics, Inc. $2,750.00 10/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1095086193 AngioDynamics, Inc. $71.92 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1095086197 AngioDynamics, Inc. $23.48 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104291976 AstraZeneca Pharmaceuticals LP $18.96 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104974251 ABBVIE INC. $24.94 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104974253 ABBVIE INC. $27.85 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104974255 ABBVIE INC. $22.74 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104974257 ABBVIE INC. $22.68 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110776975 Eisai Inc. $15.03 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125156477 Abbott Laboratories $20.65 09/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125156479 Abbott Laboratories $17.28 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139309446 Astellas Pharma US Inc $14.08 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139445872 Astellas Pharma US Inc $13.86 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144962470 Takeda Pharmaceuticals U.S.A., Inc. $72.48 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.